SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending amid analyst upgrades and renewed optimism around its robotaxi program, as highlighted by recent test drives. Community discussions revolve around the potential for a gamma squeeze and debate the company's valuation relative to traditional automakers. Some investors are also closely monitoring Wedbush's price target and potential developments with SpaceX.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to anticipation surrounding upcoming clinical trial data, particularly for RAD101, RAD202, and RAD204, with the community speculating on positive results and potential partnerships. Community members are actively discussing the company's low market capitalization, potential for significant growth, and strategic investment from Lantheus. Some traders are expressing frustration with low volume and recent price action.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending after reporting promising preliminary data from its FLAMINGO-01 trial, showing a significant reduction in breast cancer recurrence rates.  The community is actively discussing the implications of these results, especially given the potential for a buyout and the high short interest in the stock.  Despite the positive news, some traders discuss whether the stock is a "short squeeze" and express concern about the trial still needing FDA approval.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending amid community discussions about its low float and potential for a short squeeze, with some traders eyeing a possible breakout. Chatter suggests the stock may be influenced by broader market trends and speculative trading strategies. Others are closely monitoring key price levels, anticipating a volatile trading session.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray ($TLRY) is trending amid speculation surrounding potential cannabis rescheduling, driven by rumors of an upcoming announcement and a recent surge in stock price. The community is actively discussing potential catalysts and impacts on the cannabis sector, with some debating potential price movements and the possibility of a short squeeze, while others remain skeptical.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF ($MSOS) is surging amid renewed speculation that the federal government may reclassify marijuana, potentially offering tax relief and boosting profitability for cannabis businesses. Community discussions revolve around whether this time is different, with many citing past false starts and the need for confirmed news before fully trusting the rally. The sector-wide move is also drawing attention to specific stocks that could benefit most from the shift.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending downwards amid reports of a potential acquisition of Armis, with community chatter focusing on whether the deal will benefit the company's security offerings, or drag down its stock price. KeyBanc's recent downgrade to 'underweight' from 'sector weight' adds to investor concerns. Despite positive earnings and AI-driven growth, broader market sentiment is weighing on NOW, raising questions about its valuation and future performance relative to competitors.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending after reporting positive Phase 2 trial results for its CAR-T cell therapy in stiff person syndrome, leading to plans for a BLA submission in 1H 2026.  The community is discussing the potential of miv-cel to become the first approved therapy for SPS and the first CAR T treatment for autoimmune disease, while also highlighting the company's strong financial position and acquisition potential. Some are concerned about the niche market affecting sales and stability, while others are excited about the possibility of a double-digit valuation.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

AVGO is trending downwards despite recent positive earnings reports and analyst upgrades, with community sentiment reflecting concerns about potential overvaluation and margin compression in the AI sector. Some traders suspect manipulation by institutional investors, while others view the dip as a buying opportunity amidst a broader rotation out of AI stocks. The stock's heavy reliance on a few major customers is also being discussed as a potential risk.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power Corp is trending as investors react to recent price drops and an updated rating from Goldman Sachs, while also weighing the long-term potential of small modular reactor (SMR) technology to power AI data centers. Community discussions revolve around potential entry points, the impact of Fluor selling its stake, and whether the current valuation accurately reflects the company's future prospects. The focus remains on the need for reliable, carbon-free energy sources to support the growing demands of the AI industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MNMD   Any realistic chance this can hit $100? Is $CMPS the better play in this sector?

Raul King

Olivia Brandt

$MNMD $CMPS 50 easy 100 hard but doable with time

StockTwits Web

Michael Nauss

StockTwits for iOS

Mind Medicine Inc - Ordinary Shares (Sub Voting)

COMPASS Pathways

   Any realistic chance this can hit $100? Is 

@mora9127 less familiar with mnmd but it&#39;s a strong play too. Some people say cmps is a weak play because comp360 is psilocybin, and psilocybin can be found in nature and grown at home. They&#39;re missing the point entirely and it&#39;s an incredibly flimsy argument. 

People that don&#39;t need the clinical setting, proof of medical research and development, etc are already micro dosing shrooms at home. And they won&#39;t magically switch to comp360 when available. There will be two separate markets: medicinal and recreational (a similar but incongruent delineation would be Responsible/Irresponsible use). Also consider the ease of legal purchase vs homegrowing. Just like for literally every other thing clarified as a &quot;drug&quot;: cannabis, opioids, alcohol, caffeine, nasal spray, allergy meds, paint/adhesives, helium, etc. The list is infinite. 

Just my 2 cents. They&#39;re all good plays but my main bets are Atai/Compass. I&#39;m indirectly holding a lot of the rest through $PSIL

Ron S

StockTwits For Android 

AdvisorShares Psychedelics ETF

 less familiar with mnmd but it's a strong play too. Some people say cmps is a weak play because comp360 is psilocybin, and psilocybin can be found in nature and grown at home. They're missing the point entirely and it's an incredibly flimsy argument. 

People that don't need the clinical setting, proof of medical research and development, etc are already micro dosing shrooms at home. And they won't magically switch to comp360 when available. There will be two separate markets: medicinal and recreational (a similar but incongruent delineation would be Responsible/Irresponsible use). Also consider the ease of legal purchase vs homegrowing. Just like for literally every other thing clarified as a "drug": cannabis, opioids, alcohol, caffeine, nasal spray, allergy meds, paint/adhesives, helium, etc. The list is infinite. 

Just my 2 cents. They're all good plays but my main bets are Atai/Compass. I'm indirectly holding a lot of the rest through 